Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Peptimmune Gets License To Obesity Drug From Genzyme

May 11, 2004

By Aaron Lorenzo

Celera Genomics Sells All Shares Of Discovery Partners For $36M

May 7, 2004

By Aaron Lorenzo

Celera Genomics Sells All Shares Of Discovery Partners For $36M

May 7, 2004

By Aaron Lorenzo

TriMed Focuses On Developing MAA Protein For Multiple Uses

May 6, 2004

By Aaron Lorenzo

Biolex Grows MAb Capabilities Through Acquisition Of Epicyte

May 6, 2004

By Aaron Lorenzo

Biolex Grows MAb Capabilities Through Acquisition Of Epicyte

May 6, 2004

By Aaron Lorenzo

TriMed Focuses On Developing MAA Protein For Multiple Uses

May 6, 2004

By Aaron Lorenzo

Axonyx Brings In Another $20M Through Sale Of Stock, Warrants

May 5, 2004

By Aaron Lorenzo

Axonyx Brings In Another $20M Through Sale Of Stock, Warrants

May 5, 2004

By Aaron Lorenzo

MannKind Registers For IPO To Support Diabetes Product

May 4, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...